6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2,4-dione, 95.0%, 5g

5-Bromo-N-cyclopropyl-2-thiophenecarboxamide, 95.0%, 1g

(2S,6S)-tert-Butyl 2,6-dimethylpiperazine-1-carboxylate, 95.0%, 100g

3-(5-Chloropyridin-2-yl)-3-oxopropanenitrile, 97%, 100mg

3-(N,N-Diethylamino)propyltrimethoxysilane, 95%, 100g

(3-Bromo-5-fluorophenyl)boronic acid, 98.0%, 25g

(1,5-Dimethyl-1H-pyrazol-4-yl)methanol, 95.0%, 10g

DL-Cystine, min. 98.5%, 1 g, glass packaging

(R)-3-((tert-Butoxycarbonyl)amino)-4-(3-fluorophenyl)butanoic acid, 95.0%, 250mg

Triethoxy(1H,1H,2H,2H-nonafluorohexyl)silane>97.0%(GC)5g

cis-5-Norbornene-endo-2,3-dicarboxylic Acid>98.0%(GC)(T)5g

2-Amino-4,5-dimethylbenzoic Acid>97.0%(HPLC)(T)200mg

N-Boc-Propargylglycine methyl ester, 97.0%, 100mg